RegulyzePatwar topi
Scutellaria bicalensis
Patwar topi (Scutellaria bicalensis) is a nutraceutical permitted for use in nutraceuticals and health supplements under India's FSSAI framework, with a permitted limit of 250-1000 mg/day max. Regulyze tracks its regulatory status, limits and label requirements across regulatory frameworks.
Regulatory status
| Framework | Status | Limit | Source | Last reviewed |
|---|---|---|---|---|
| India — FSSAI | Permitted | 250-1000 mg/day max | FSS (Health Supplements, Nutraceuticals…) Regulations 2022 | 2026-06-20 |
Coverage for the USA (FDA), EU (EFSA), UK, GCC and ASEAN is being added — this page updates automatically as frameworks are assessed.
About Patwar topi
Patwar topi is tracked in the Regulyze Ingredient Intelligence database as a nutraceutical (Scutellaria bicalensis). The regulatory details on this page are generated from Regulyze's structured regulatory dataset and are reviewed against the cited source.
Frequently asked questions
Is Patwar topi permitted in nutraceuticals under FSSAI (India)?
Patwar topi (Scutellaria bicalensis) (listed in the regulation as “Scutellaria bicalensis”) is currently permitted for use in health supplements and nutraceuticals under India's FSSAI framework, per FSS (Health Supplements, Nutraceuticals…) Regulations 2022. Always verify against the current official regulation for your product and market.
What is the permitted dosage of Patwar topi?
The permitted level recorded for Patwar topi is 250-1000 mg/day max. Limits can vary by product type and market — confirm against the current regulation.
What product category does Patwar topi belong to?
Patwar topi is classified under: Nutraceuticals, Botanicals.
What is the botanical (scientific) name of Patwar topi?
Patwar topi corresponds to Scutellaria bicalensis.
Source: FSS (Health Supplements, Nutraceuticals…) Regulations 2022 · Last reviewed: 2026-06-20 · Data version: db-2026-06-20. Indicative only — verify against the current official regulation before use.